Androgen & Reproductive Disorders
Investigators aimed to determine the prevalence of fatigue in women diagnosed with endometriosis.
Investigators aimed to determine the level of midluteal progesterone associated with low probability of live birth following intrauterine insemination.
Only half of patients with initial treatment success maintain benefits at two years.
Symptoms more likely in those reporting fair health, history of non-spontaneous menopause
Menopausal hormone therapy may slow cognitive decline in postmenopausal women with mild cognitive impairment.
Researchers sought to determine whether the reduced mortality seen in women receiving reproductive assistance occurred as a result of improved general health in this population.
Researchers assessed the effect of testosterone, estradiol, dehydroepiandrosterone, and sex hormone-binding globulin levels on coronary heart disease, heart failure, and cardiovascular disease in postmenopausal women.
The management of asthma with short-acting beta-agonists was associated with reduced fertility rates in women, whereas treatment with inhaled corticosteroids or long-acting beta-agonists was not.
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
A new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception.
In a limited systematic review, hormonal therapy with gonadotropin-releasing hormone analogs produced some suppression of secondary sexual function, with more success in promoting anticipated masculinization or feminization with the use of testosterone or estrogen, respectively.
Testosterone levels were increased in women with stable multi-episode schizophrenia and decreased in men with stable multi-episode schizophrenia.
Researchers examined the correlation between Cobb angle of kyphosis from lateral spine radiographs and pattern of self-reported menopausal hormone therapy use.
Variable improvements in menses, hormones, and metabolism were seen during 24 months of metformin use in 119 women with PCOS sub-grouped by baseline weight and androgen status.
Study evaluated the difference in the rate of ongoing pregnancy or live birth between frozen embryo transfer and fresh embryo transfer in women without polycystic ovary syndrome who were undergoing IVF.
Exposure to air pollution during high school is associated with a slightly higher likelihood of menstrual irregularity and longer time to regularity.
The FDA has approved Zomacton, a somatropin injection, for the replacement of growth hormone in adults with GH deficiency.
Medicaid policy encourages the use of long-acting reversible contraception, but state-level payment policies are inconsistent and often do not include critical aspects of care.
Researchers have found that lower alpha diversity is seen in women with polycystic ovary syndrome vs healthy women.
Women with migraine with aura are at an increased risk for stroke if they are taking high-dose estrogen-containing contraceptives.
The stair-step clomiphene protocol is associated with decreased time to ovulation for women with polycystic ovary syndrome.
A nonhormonal treatment option for the relief of symptoms associated with menopause is now available alongside other drug-free supplements.
No differences were observed in live-birth rate, rates of implantation, clinical pregnancy, overall pregnancy loss, or ongoing pregnancy incidents between ovulatory women with infertility who received frozen-embryo or fresh-embryo transfers.
To update its 2012 recommendation, the US Preventive Services Task Force reviewed evidence on the benefits and harms of systemic hormone therapy for the prevention of chronic conditions in postmenopausal women.
Researchers found that 3061 postmenopausal women of 61,335 developed invasive breast cancer during a mean follow-up of 11.4 years. Women with weight loss (≥5%) had a significantly lower breast cancer risk than women with stable weight.
Products marketed as selective androgen receptor modulators and sold via the internet frequently contain unapproved drugs and substances, and the amount of active compound often does not match that listed on the label.
Although the use of fertility therapy has steadily increased in the past few decades, research findings pertaining to related long-term cardiovascular outcomes are scarce and conflicting.
Guideline was developed under the direction of the Practice Committee of the American Society for Reproductive Medicine.
Long-term exposure to progestin-only oral contraceptives or to a progestin intrauterine device is associated with a small beneficial effect on pelvic girdle pain.
Asthma may increase the likelihood of a woman needing fertility treatments prior to becoming pregnant.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
- New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow